Please Note: There is no Medicare information on our corporate website. Please select a specific contract in the 'Search Within' box for Medicare related information.
© 2020 Palmetto GBA, LLC
We frequently update our articles to reflect the latest changes and updates to Medicare, and strongly recommend you visit this article at link below to confirm you have the latest version.
Printed Date: 9/22/2015
Interested parties with Food and Drug Administration (FDA) approval letters dated January 1, 2015 or later for IDE Category A or Category B studies that are seeking Medicare coverage for Category A or B IDE studies must submit a request packet to CMS. Please follow instructions found on the Medicare Coverage Related to Investigational Device Exemption (IDE) Studies CMS web page. Palmetto GBA does not require notification for CMS approvals.
Interested parties with Food and Drug Administration (FDA) approval letters dated prior to January 1, 2015, should submit the following information to Palmetto GBA prior to submission of a claim for payment:
This information should be forwarded to one of the following:
Jurisdiction M (North Carolina, South Carolina, Virginia and West Virginia)
If you need to request approval for both Part A and Part B you may do so within the same packet of information. Please indicate this request on your cover letter. You may submit this packet to one of the options above.
If approved, facilities will receive an authorization letter from Palmetto GBA. Providers should adhere to the billing requirements described in CMS Internet-Only Manual, Pub 100-02, Medicare Benefit Policy Manual, Chapter 14, Sections 20-110 (PDF, 55 KB) and CMS Internet-Only Manual, Pub 100-04, Medicare Claims Processing Manual, Chapter 32, Section 68 (PDF, 1.54 MB) to ensure the proper processing of IDE claims.
NOTE: The term "Clinical Trials" is not synonymous with "IDE." Available Medicare coverage for each is based on different standards. Refer to CMS Internet-Only Manual, Pub 100-03, Medicare National Coverage Determinations (NCDs) Manual, Chapter 1, Part 4, Section 310.1 (PDF, 1 MB) and CMS Internet-Only Manual, Pub 100-04, Medicare Claims Processing Manual, Chapter 32, Section 69 (PDF, 1.54 MB) to ensure proper processing of claims for qualifying clinical trial services.
For additional billing requirements related to "no cost items" please see CMS Internet-Only Manual, Pub 100-04, Medicare Claims Processing Manual, Chapter 32, Section 67 (PDF, 1.54 MB).
We value your opinion and want to provide the highest-quality and most relevant Medicare knowledge possible. Please let us know if this article was helpful.
It didn't answer my question
This article was helpful
We’re glad we could help you today and appreciate your feedback. When you rate our articles as most helpful, we know that we are on the right track for providing you with important news and information.
We're sorry this article didn't help you today. We'll use your feedback to review this article to try to revise or expand it. Contact us with more feedback or a question on this topic.
Last Updated: 06/05/2019